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Abstract
Microarray datasets have been interrogated to determine whether the expression of 
vitamin D-related genes is modulated in adipocytes during inflammation. The datasets 
were from human adipocytes and preadipocytes incubated with macrophage-
conditioned medium (U937 cells). in adipocytes, exposure to the conditioned medium 
for 24 h resulted in a major increase (82.2-fold) in mRNA level of CYP27B1, the gene 
encoding the enzyme that converts 25-hydroxycholecalciferol to the active form of 
vitamin D3, 1,25-dihydroxycholecalciferol; exposure for 4 h also raised CYP27B1 mRNA 
level (10.9-fold). The level of the mRNA encoding the vitamin D receptor (vDR) was 
increased after 24 h (7.7-fold), but there was no change at 4 h. in contrast, incubation with 
conditioned medium for either 4 or 24 h had no effect on the expression of the CYP24 
and CYP2R1 genes, which encode enzymes that catalyse a 24-hydroxylation and the 
conversion of vitamin D3 to 25-hydroxycholecalciferol, respectively. in preadipocytes, 
the only effect of the macrophage-conditioned medium was to stimulate CYP27B1 
expression (5.7-fold) after 24 h.  it is concluded that the capacity of adipocytes to 
produce active vitamin D3 hormone and its nuclear receptor is strongly upregulated 
by secretory products from macrophages; this is consistent with a counter-regulatory 
effect of the vitamin D system to ameliorate inflammation.
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Introduction
Microarray studies have examined 
global gene expression in adipose 
tissue and in adipocytes in particu-
lar, and the changes that take place 
in response to specific stimuli (1-5). 
Our own studies have focused on the 
effects of macrophage secretions on 
gene expression in human adipocytes 
and preadipocytes in culture (6-7). 
Bioinformatic analysis of microar-
ray data allows major networks and 
pathways that are modulated in par-
ticular conditions, or in response to 
specific stimuli, to be identified. These 
pathways, together with the individ-
ual genes whose expression is altered 
most extensively, are normally the 
main focus of interest; this is certainly 
so during the initial analysis. For ex-
ample, in our studies on the effect of 
macrophage secretions on adipocyte 
gene expression, a group of matrix 
metalloproteinases (MMP1, MMP3, 
MMP10) where the mRNA level in-
creased by >1000-fold were of key 
interest, as were the major pathways 
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activated - which included those associated with inflammation 
and macrophage infiltration (6). 
Microarrays are a rich source of data beyond the major path-
ways and highly differentially expressed genes, and interroga-
tion of the datasets can provide important insight in unexpected 
areas. One of the emerging interests in adipobiology is the extent 
to which adipocytes are involved in vitamin D metabolism, both 
in relation to the storage of the hormone and as a target tissue. 
In this short article we describe the outcome of examination of 
our microarray data for genes encoding the vitamin D receptor 
(VDR) and enzymes involved in the synthesis of the active hor-
mone (CYP27B1 and CYP2R1). 
vitamin d
The vitamin D endocrine system has been linked historically to 
calcium homeostasis and bone metabolism, with rickets being 
the classical deficiency disease (8-10). However, it is increasingly 
evident that this hormonal system is involved in a range of phys-
iological functions. The main route by which vitamin D is ob-
tained is by endogenous synthesis in the skin, though provision 
through the diet is important for those populations who live in 
regions where sunlight is limited, or where exposure to the sun 
is restricted for cultural reasons or because of factors such as age. 
The main dietary sources of vitamin D are oily fishes (especially 
the liver), eggs, and full-fat milk.
The term ‘vitamin D’ is used somewhat loosely and it is im-
portant to note that it is not strictly a vitamin in the sense of 
being an essential dietary nutrient, given the synthesis in the 
skin. Furthermore, vitamin D in practise refers essentially to 
D3 (cholecalciferol), the only form of the vitamin that is found 
naturally in humans and other animals (8-9).
Vitamin D metabolism
Vitamin D3 is synthesised in the skin non-enzymatically from 
7-dehydrocholesterol through irradiation by UV light. The 
product of irradiation, precalciferol, isomerises to cholecalcif-
erol. This is then transported to the liver bound to a plasma 
transport protein, Gc-globulin (also known as transcalciferin). 
Dietary-derived vitamin D3 is absorbed and transferred to the 
liver in chylomicrons. Vitamin D3, whether from endogenous 
synthesis in the skin or from the diet, is then hydroxylated in 
the liver to form 25-hydroxycholecalciferol (or calcidiol). The 
released 25(OH)D3, which is the main circulating form of vi-
tamin D3 hormone, is further hydroxylated to form 1,25-dihy-
droxycholecalciferol (or calcitriol), and this occurs primarily in 
the kidney (8-9). The enzyme that catalyses this second hydrox-
ylation is 25(OH)D3-1α-hydroxylase, and is present in at least 
ten other tissues additional to the kidney (9). A 24-hydroxyla-
tion can also occur in the kidney (and other tissues) to form 
24,25-dihydroxycholecalciferol. The main route for the degrada-
tion of 1,25(OH)2D3 is also through a 24-hydroxylation.
There are two modes of action of 1,25(OH)2D3 – genomic and 
non-genomic (11). The actions on gene transcription are medi-
ated through a specific nuclear receptor, the vitamin D receptor 
(VDR). This receptor is widely expressed, expression being re-
ported in a number of tissues (11). The transcription of as many 
as 500 genes may be regulated through VDR. There are also rap-
id responses to 1,25(OH)2D3 which occur within minutes and 
which do not involve gene transcription, such as the stimulation 
of intestinal calcium transport. The current view is that VDR is 
present not only in the nucleus, but also in calveolae associated 
with the plasma membrane of target cells, and is the receptor 
for the non-genomic as well as genomic actions of 1,25(OH)2D3 
(11). 
Functions of vitamin D
Vitamin D has long been recognised to play a central role in 
the stimulation of calcium absorption by the intestine and in the 
mineralisation and re-modelling of bone (8-10). Indeed, vitamin 
D deficiency is closely associated with the development of rick-
ets in children and osteomalacia in adults. Other functions are 
now increasingly evident, particularly in relation to the immune 
system (10,12,13). Examples include an anti-inflammatory ac-
tion in macrophages, with the down-regulation of the produc-
tion of tumor necrosis factor-alpha (TNF-α) through a decrease 
in NFkB activity (14-15). Indeed, an anti-inflammatory action 
seems to be a characteristic of 1,25(OH)2D3. Other major actions 
of the hormone include the stimulation of insulin secretion by 
pancreatic β cells, vitamin D deficiency leading to the inhibition 
of secretion (9, 16). 
A growing number of diseases have been linked to vitamin 
D status, apart from rickets and osteomalacia, and these include 
several types of cancer (breast, colon and prostate) (9). In addi-
tion, inflammatory bowel disease, hypertension, peridontal dis-
ease, multiple sclerosis and muscle weakness (especially in the 
elderly) have each been associated with vitamin D insufficiency 
(9-10,13). Of particular relevance to obesity is the proposed link 
with cardiometabolic diseases (atherosclerosis, hypertension, 
type 2 diabetes and the metabolic syndrome). Indeed, a recent 
editorial in the Journal of Clinical Endocrinology and Metabolism 
was provocatively titled “25-OH vitamin D: is it the universal 
panacea for metabolic syndrome and type 2 diabetes?” (17). 
Vitamin D status is considered to be best assessed by the se-
rum level of 25(OH)D3 (9). The circulating level of 1,25(OH)2D3 
is of the order of 1000 times lower than that of 25(OH)D3. Sever-
al epidemiological studies have demonstrated an inverse corre-
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on the effect of macrophage-conditioned (MC) medium on 
global gene expression in human adipocytes (Simpson-Golabi-
Beymel Syndrome - SGBS) at short and longer time points – 4 
and 24 h (6). The other was on the effects of MC medium on 
gene expression in human preadipocytes (SGBS), following a 24 
h incubation with the medium (7). In both sets of studies, the 
comparison was with adipocytes/preadipocytes incubated in 
unconditioned macrophage (UC) medium – the medium used 
to culture macrophages, but which had not been exposed to cells 
(150 μl of UC or MC medium added per ml of preadipocyte/
adipocyte medium). The macrophages were derived from U937 
monocytes, which had been induced to differentiate through the 
addition of phorbol myristic acid.
The microarray data was interrogated for whether the treat-
ments affected the expression of four genes associated with the 
metabolism and action of the vitamin D3 system. These genes 
were: (i) CYP27B1 (encodes the 1α-hydroxylase), (ii) CYP2R1 
(encodes the 25-hydroxylase), (iii) CYP24 (encodes the 24-hy-
droxylase that degrades 1,25(OH)2D3), and (iv) VDR (encodes 
the vitamin D receptor). In human adipocytes exposed to MC 
medium, major changes in CYP27B1 expression were observed; 
the CYP27B1 mRNA level was increased 10.9 fold at 4 h and by 
as much as 82-fold at 24 h (Fig 1). At 24 h this gene was ranked 
number 40 out of 1307 genes whose expression was up-regulat-
ed by the conditioned medium, indicating that it is one of the 
most highly responsive genes to macrophage-secreted factors in 
human adipocytes. In contrast, there was no change in CYP24 
expression, nor in CYP2R1. VDR mRNA level increased 7.7-
fold at 24 h, though there was no change at 4 h, indicating that 
expression of the vitamin D receptor is increased by prolonged 
exposure to MC medium (Fig 1).
In human preadipocytes exposed to MC medium for 24 h, 
no changes in VDR, CYP2R1, or CYP24 mRNA levels were 
observed (Fig 2). However, there was an increase in CYP27B1 
mRNA level (5.7-fold) and this gene ranked at number 34 in the 
list of 401 genes that were up-regulated in preadipocytes by MC 
medium (Fig 2). The up-regulation of CYP27B1 gene expression 
in preadipocytes induced by macrophage secretions indicates 
that the capacity of adipocytes to hydroxylate 25(OH)D3 is not 
differentiation-dependent.
A further microarray dataset that was available to us on 
the effects of exposure to hypoxia (1% O2) for 24 h on global 
gene expression in human adipocytes was also examined. 
No changes in expression were found for CYP27B1, CYP24, 
CYP2R1, or VDR, the mRNA levels for each of these genes 
being similar in adipocytes exposed to normoxia (21% O2) 
or hypoxia. Thus vitamin D3 system genes are not hypoxia-
sensitive in adipocytes.
lation in adults between body mass index (BMI) and circulating 
25(OH)D3 level (18-20). In practise, it is the amount of body fat 
that is important. The explanation for the relationship with obe-
sity is not clear, but it is possible that the hormone is sequestered 
within adipose tissue by virtue of the high lipid solubility. If this 
is the case, then low serum 25(OH)D3 levels are not indicative of 
an insufficiency of vitamin D per se. An alternative explanation 
for low serum levels in obesity is that adipocytes, or other cells 
within adipose tissue, have the capacity to degrade the steroid 
hormone.
Vitamin D and adipose tissue
White adipose tissue and adipocytes are among the extra-renal 
sites of expression of the 1α-hydroxylase gene (CYP27B1), and 
the conversion of 25(OH)D3 to 1,25(OH)2D3 has been directly 
demonstrated, including in preadipocytes and in human mam-
mary adipocytes (21-22). The vitamin D receptor is also ex-
pressed in mouse preadipocytes and adipocytes (22-26). Treat-
ment of 3T3-L1 cells with 25(OH)D3 has been reported to induce 
expression of CYP24, a 1,25(OH)2D3 responsive gene (21). There 
is also evidence that 1,25(OH)2D3 may increase lipid synthesis 
in human adipocytes; however, contrastingly, the expression of 
Insig-2, a gene that encodes a protein that is involved in inhibit-
ing fat synthesis, is stimulated by 1,25(OH)2D3 (27). The aug-
mentation of glucocorticoid production in adipocytes through 
a (small) upregulation of 11β-hydroxysteroid dehydrogenase 
type 1 expression by 1,25(OH)2D3 has been observed (28). The 
favouring of inflammatory cytokine production (TNF-α and 
IL-6) in adipocytes and the suppression of anti-inflammatory 
cytokine production by 1,25(OH)2D3 has also been reported in 
3T3-L1 adipocytes and in human adipose cells (29). However, 
a very recent study showed that 1,25(OH)2D3 reduced the re-
lease of monocyte chemotactic protein-1 (MCP-1), also known 
as chemokine (C-C motif) ligand 2 (CCL2), and adiponectin by 
human adipocytes (30). This suggests that vitamin D3 may have 
both pro- and anti-inflammatory effects in human fat cells.
Several studies have investigated the effects of 1,25(OH)2D3 
on adipocyte differentiation and proliferation, and while both an 
augmentation and an inhibition have been reported the growing 
consensus is that the hormone has primarily an inhibitory ac-
tion on fat cell recruitment (22,31-32).
Interrogation of microarrays
In a preliminary exploration of the extent to which adipose tis-
sue may be a significant site of vitamin D3 metabolism and a 
target tissue of the hormone, we examined two different micro-
array datasets for the expression of genes involved in the vitamin 
D3 endocrine system. The first microarrays were from a study 
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Figure 1. Effect of macrophage-conditioned medium on 
the expression of vitamin D3-related genes in human adi-
pocytes. Gene expression was assessed by microarrays fol-
lowing 4 and 24 h exposure to the conditioned medium. The 
fold-changes relate to the conditioned medium compared to 




The GeO accession number is GSe14312.
Figure 2. Effect of macrophage-conditioned medium on 
the expression of vitamin D3-related genes in human pre-
adipocytes. Gene expression was assessed by microarrays 
following 24 h exposure to the conditioned medium. The 
fold-changes relate to the conditioned medium compared to 
unconditioned medium. The data may be reviewed through 
the following link:
http://www. ncbi. nlm. nih.gov/geo/query/acc.cgi?token = 
rfqfjamewuwmors&acc= 
The GeO accession number is GSe27503.
conclusion
This analysis of microarray datasets confirms that human adi-
pocytes express the genes encoding the 1α-hydroxylase that 
converts 25(OH)D3 to 1,25(OH)2D3, and the VDR, and demon-
strates that the expression of both genes is markedly stimulated 
by MC medium. Thus the capacity of adipocytes to produce the 
active vitamin D3 hormone and its nuclear receptor would ap-
pear to be strongly upregulated by secretory products released 
by macrophages (assuming that the changes in mRNA are mir-
rored at the protein level). Given the apparent anti-inflammatory 
actions of 1,25(OH)2D3, the upregulation of VDR and CYP27B1 
expression in adipocytes on exposure to macrophage-secreted 
products would suggest a counter-regulatory response to ame-
liorate inflammation. The stimulation of VDR expression by in-
flammatory mediators is consistent with a local action within 
adipose tissue for increased 1,25(OH)2D3 produced during in-
flammation. 
The strong upregulation of CYP27B1 by MC medium raises 
the intriguing possibility that adipocytes are a significant site of 
the generation of 1,25(OH)2D3 under inflammatory conditions. 
Obesity is, of course, characterised by chronic mild inflamma-
tion, and adipose tissue exhibits a substantial inflammatory 
response in the obese (33-35). This involves macrophage re-
cruitment in the tissue, as well as the production of inflamma-
tion-related factors by adipocytes including pro-inflammatory 
cytokines and chemokines (36,37). The nature of the factors se-
creted from adipocytes that stimulate transcription of the VDR 
and CYP27B1 genes in adipocytes is unclear. However, cytokines 
such as TNF-α and IL-1β may well play a key role, similar to 
their action in stimulating matrix metalloproteinase expression 
and release (6).
In conclusion, the present report illustrates the information 
and insight that can be obtained through the mining of microar-
ray datasets.
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